List Of Over 100 Studies Proving How COVID Vaccines Are More Harmful Than What We’re Being Told

I will say this, when all of this is over and it will end, it has to, then we must get accountability for it is way past simple mistakes.

Some of this is malfeasance, yes greed that will wrap itself up into any matter, but there is real malfeasance.

Anyone who did wrong in this COVID, under Trump and Biden, anyone, anyone who profited, anyone who abused their position and anyone who costed lives, must sit in a jail cell for some time.

This is part of the healing, not simple mea culpas. No ride off into the sunset with a golden parachute. We want jail!

List of Studies Showing How Harmful COVID Vaccines Are

Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study:

Fatal cerebral hemorrhage after COVID-19 vaccine:

Myocarditis after mRNA vaccination against SARS-CoV-2, a case series:

Three cases of acute venous thromboembolism in women after vaccination against COVID-19:

Clinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOx1 nCov-19;

CAd26.COV2-S vaccination may reveal hereditary thrombophilia: massive cerebral venous sinus thrombosis in a young man with normal platelet count:

Post-mortem findings in vaccine-induced thrombotic thrombocytopenia:

COVID-19 vaccine-induced thrombosis:

Inflammation and platelet activation after COVID-19 vaccines: possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis:

Anaphylactoid reaction and coronary thrombosis related to COVID-19 mRNA vaccine:

Vaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford-AstraZeneca COVID-19: a missed opportunity for rapid return on experience:

Occurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19:

Deep venous thrombosis more than two weeks after COVID-19 vaccination:

Case report: Take a second look: Cerebral venous thrombosis related to Covid-19 vaccination and thrombotic thrombocytopenia syndrome:

Information on ChAdOx1 nCoV-19 vaccine-induced immune-mediated thrombotic thrombocytopenia:

Change in blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome:

Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT):

Bilateral thalamic stroke: a case of COVID-19 (VITT) vaccine-induced immune thrombotic thrombocytopenia or a coincidence due to underlying risk factors:

Thrombocytopenia and splanchnic thrombosis after vaccination with Ad26.COV2.S successfully treated with transjugular intrahepatic intrahepatic portosystemic shunt and thrombectomy:

Incidence of acute ischemic stroke after coronavirus vaccination in Indonesia: case series:

Successful treatment of vaccine-induced immune immune thrombotic thrombocytopenia in a 26-year-old female patient:

Case report: vaccine-induced immune immune thrombotic thrombocytopenia in a patient with pancreatic cancer after vaccination with messenger RNA-1273:

Idiopathic idiopathic external jugular vein thrombophlebitis after coronavirus disease vaccination (COVID-19):

Squamous cell carcinoma of the lung with hemoptysis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech):

Vaccine-induced thrombotic thrombocytopenia after Ad26.COV2.S vaccination in a man presenting as acute venous thromboembolism:

Myocarditis associated with COVID-19 vaccination in three adolescent boys:

Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination: a case series:

Perimyocarditis after vaccination with COVID-19:

Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination:

Myocarditis-induced sudden death after BNT162b2 COVID-19 mRNA vaccination in Korea: case report focusing on histopathological findings:

Acute myocarditis after vaccination with COVID-19 mRNA in adults aged 18 years or older:

Recurrence of acute myocarditis temporally associated with receipt of the 2019 coronavirus mRNA disease vaccine (COVID-19) in an adolescent male:

Young male with myocarditis after mRNA-1273 coronavirus disease-2019 (COVID-19) mRNA vaccination:

Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old male:

Ga-DOTATOC digital PET images of inflammatory cell infiltrates in myocarditis after vaccination with COVID-19:

Occurrence of acute infarct-like myocarditis after vaccination with COVID-19: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?”:

Self-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with BNT162b2 mRNA vaccine:

Myocarditis Following Immunization with COVID-19 mRNA Vaccines in Members of the U.S. Military:

Myocarditis after BNT162b2 vaccination in a healthy male:

Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report:

Acute myocarditis after SARS-CoV-2 mRNA-1273 mRNA vaccination:

Chest pain with abnormal electrocardiogram redevelopment after injection of COVID-19 vaccine manufactured by Moderna:

Biopsy-proven lymphocytic myocarditis after first vaccination with COVID-19 mRNA in a 40-year-old man: case report:

Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after vaccination with mRNA-1273:

Report of a case of myopericarditis after vaccination with BNT162b2 COVID-19 mRNA in a young Korean male:

Acute myocarditis after Comirnaty vaccination in a healthy male with previous SARS-CoV-2 infection:

Acute myocarditis in a young adult two days after vaccination with Pfizer:

Case report: acute fulminant myocarditis and cardiogenic shock after messenger RNA coronavirus vaccination in 2019 requiring extracorporeal cardiopulmonary resuscitation:

Acute myocarditis after 2019 coronavirus disease vaccination:

A series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2:

Myopericarditis after Pfizer messenger ribonucleic acid coronavirus coronavirus disease vaccine in adolescents:

Post-vaccination multisystem inflammatory syndrome in adults without evidence of prior SARS-CoV-2 infection:

Acute myocarditis defined after vaccination with 2019 mRNA of coronavirus disease:

Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination:

Myocarditis following COVID-19 vaccination: MRI study:

Acute myocarditis after COVID-19 vaccination: case report:

Association of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine COVID-19 in a case series of children:

Clinical suspicion of myocarditis temporally related to COVID-19 vaccination in adolescents and young adults:

Myocarditis following vaccination with Covid-19 in a large healthcare organization:

AstraZeneca COVID-19 vaccine and Guillain-Barré syndrome in Tasmania: a causal link:

COVID-19, Guillain-Barré and vaccineA dangerous mix:

Guillain-Barré syndrome after the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases:

Guillain-Barre syndrome after BNT162b2 COVID-19 vaccine:

COVID-19 adenovirus vaccines and Guillain-Barré syndrome with facial palsy:

Association of receipt association of Ad26.COV2.S COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021:

A case of Guillain-Barré syndrome after Pfizer COVID-19 vaccine:

Guillain-Barré syndrome associated with COVID-19 vaccination:

Rate of recurrent Guillain-Barré syndrome after COVID-19 BNT162b2 mRNA vaccine:

Guillain-Barre syndrome after COVID-19 vaccination in an adolescent:

Guillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccination:

Guillain-Barre syndrome after COVID-19 mRNA-1273 vaccine: case report:

Guillain-Barre syndrome following SARS-CoV-2 vaccination in 19 patients:

Guillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients:

A rare case of Guillain-Barré syndrome after COVID-19 vaccination:

Neurological complications of COVID-19: Guillain-Barre syndrome after Pfizer COVID-19 vaccine:

COVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effect:

Guillain-Barre syndrome after the first dose of COVID-19 vaccination: case report;

Miller Fisher syndrome after Pfizer COVID-19 vaccine:

Miller Fisher syndrome after 2019 BNT162b2 mRNA coronavirus vaccination:

Bilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine:

Guillain-Barre syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report:

A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies after first dose of COVID-19 BNT162b2 mRNA vaccine (Pfizer):

Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analysis in VigiBase:

A variant of Guillain-Barré syndrome after SARS-CoV-2 vaccination: AMSAN:

A rare variant of Guillain-Barré syndrome after vaccination with Ad26.COV2.S:

Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome:

Guillain-Barré syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-2 vaccines:

Acute transverse myelitis after SARS-CoV-2 vaccination: case report and review of the literature:

Variant Guillain-Barré syndrome occurring after SARS-CoV-2 vaccination:

Guillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-2 mRNA-based vaccine:

Guillain-Barre syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association:

SARS-CoV-2 vaccines can be complicated not only by Guillain-Barré syndrome but also by distal small fiber neuropathy:

Clinical variant of Guillain-Barré syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine:

Adverse event reporting and risk of Bell’s palsy after COVID-19 vaccination:

Bilateral facial nerve palsy and COVID-19 vaccination: causality or coincidence:

Left Bell’s palsy after the first dose of mRNA-1273 SARS-CoV-2 vaccine: case report:

Bell’s palsy after inactivated vaccination with COVID-19 in a patient with a history of recurrent Bell’s palsy: case report:

Neurological complications after the first dose of COVID-19 vaccines and SARS-CoV-2 infection:

Type I interferons as a potential mechanism linking COVID-19 mRNA vaccines with Bell’s palsy:

Acute transverse myelitis following inactivated COVID-19 vaccine:

Acute transverse myelitis after COVID-19 vaccination:

A case of longitudinally extensive transverse myelitis following Covid-19 vaccination:

Post COVID-19 transverse myelitis; a case report with review of the literature:

Beware of neuromyelitis optica spectrum disorder after vaccination with inactivated virus for COVID-19:

Neuromyelitis optica in a healthy woman after vaccination against severe acute respiratory syndrome coronavirus 2 mRNA-1273:

Acute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2:

A case series of acute pericarditis after vaccination with COVID-19 in the context of recent reports from Europe and the United States:

Acute pericarditis and cardiac tamponade after vaccination with Covid-19:

Myocarditis and pericarditis in adolescents after the first and second doses of COVID-19 mRNA vaccines:

Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine:

Acute myopericarditis after COVID-19 vaccine in adolescents:

Pericarditis after administration of the BNT162b2 mRNA vaccine COVID-19:

Case report: symptomatic pericarditis post COVID-19 vaccination:

An outbreak of Still’s disease after COVID-19 vaccination in a 34-year-old patient:

Hemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19):

Myocarditis after SARS-CoV-2 mRNA vaccination, a case series:

Miller-Fisher syndrome and Guillain-Barré syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-2 vaccination:

Immune-mediated disease outbreaks or new-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2:

Post-mortem investigation of deaths after vaccination with COVID-19 vaccines:

Acute kidney injury with macroscopic hematuria and IgA nephropathy after COVID-19 vaccination:

Relapse of immune thrombocytopenia after covid-19 vaccination in young male patient:

Immune thrombocytopenic purpura associated with COVID-19 mRNA vaccine Pfizer-BioNTech BNT16B2b2:

Retinal hemorrhage after SARS-CoV-2 vaccination:

Case report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage can occur after COVID-19 vaccination:

Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: case report:

Peduncular, symptomatic cavernous bleeding after immune thrombocytopenia-induced SARS-CoV-2 vaccination:

Brain death in a vaccinated patient with COVID-19 infection:

Generalized purpura annularis telangiectodes after SARS-CoV-2 mRNA vaccination:

Lobar hemorrhage with ventricular rupture shortly after the first dose of a SARS-CoV-2 mRNA-based SARS-CoV-2 vaccine:

A case of outbreak of macroscopic hematuria and IgA nephropathy after SARS-CoV-2 vaccination:

Acral hemorrhage after administration of the second dose of SARS-CoV-2 vaccine. A post-vaccination reaction:

Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine:

Gross hematuria after severe acute respiratory syndrome coronavirus 2 vaccination in 2 patients with IgA nephropathy:

Autoimmune encephalitis after ChAdOx1-S SARS-CoV-2 vaccination:

COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis:

Bell’s palsy after vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and a nested case-control study:

Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule, and interval:

Anaphylaxis following Covid-19 vaccine in a patient with cholinergic urticaria:

Anaphylaxis induced by CoronaVac COVID-19 vaccine: clinical features and results of revaccination:

Anaphylaxis after Modern COVID-19 vaccine:

Association of self-reported history of high-risk allergy with allergy symptoms after COVID-19 vaccination:

Sex differences in the incidence of anaphylaxis to LNP-mRNA vaccines COVID-19:

Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14 to 23, 2020:

Allergic reactions, including anaphylaxis, after receiving the first dose of Modern COVID-19 vaccine – United States, December 21, 2020 to January 10, 2021:

Prolonged anaphylaxis to Pfizer 2019 coronavirus disease vaccine: a case report and mechanism of action:

Anaphylaxis reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis following vaccination with Pfizer BNT162b2:

Biphasic anaphylaxis after first dose of 2019 messenger RNA coronavirus disease vaccine with positive polysorbate 80 skin test result:

Acute myocardial infarction and myocarditis after COVID-19 vaccination:

Takotsubo syndrome after COVID-19 vaccination:

Takotsubo cardiomyopathy after coronavirus 2019 vaccination in patient on maintenance hemodialysis:

Premature myocardial infarction or side effect of COVID-19 vaccine:

Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 mRNA COVID-19 vaccine in persons aged 75 years or older:

Kounis syndrome type 1 induced by inactivated SARS-COV-2 vaccine:

Acute myocardial infarction within 24 hours after COVID-19 vaccination: is Kounis syndrome the culprit:

Deaths associated with the recently launched SARS-CoV-2 vaccination (Comirnaty®):

Deaths associated with recently launched SARS-CoV-2 vaccination:

A case of acute encephalopathy and non-ST-segment elevation myocardial infarction after vaccination with mRNA-1273: possible adverse effect:

COVID-19 vaccine-induced urticarial vasculitis:

ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine:

New-onset leukocytoclastic vasculitis after COVID-19 vaccine:

Cutaneous small vessel vasculitis after COVID-19 vaccine:

Outbreak of leukocytoclastic vasculitis after COVID-19 vaccine:

Leukocytoclastic vasculitis after exposure to COVID-19 vaccine:

Vasculitis and bursitis in [ 18 F] FDG-PET/CT after COVID-19 mRNA vaccine: post hoc ergo propter hoc?;

Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine:

Cutaneous leukocytoclastic vasculitis induced by Sinovac COVID-19 vaccine:

Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and crescentic Pauci-Inmune glomerulonephritis after vaccination with Pfizer-BioNTech COVID-19 mRNA:

Reactivation of IgA vasculitis after vaccination with COVID-19:

Varicella-zoster virus-related small-vessel vasculitis after Pfizer-BioNTech COVID-19 vaccination:

Imaging in vascular medicine: leukocytoclastic vasculitis after COVID-19 vaccine booster:

A rare case of Henoch-Schönlein purpura after a case report of COVID-19 vaccine:

Cutaneous vasculitis following COVID-19 vaccination:

Possible case of COVID-19 mRNA vaccine-induced small-vessel vasculitis: